NEPHRO Flashcards
definition of hematuria
presence of at least 5 RBCs per microliter of urine
Heme positive without RBCs
presence of myoglobin or hemoglobin
hematuria within the glomerulus
brown, cola or tea-colored or burgundy urine
protenuria >100mg/dl via dipstick
RBC casts
deformed urinary RBCs (acanthocyte)
hematuria arising from lower urinary tract
gross hematuria, bright red or pink terminal hematuria blood clots normal unrinary RBC morphology minimal proteinuria on dipstick (<100mg/dL)
tea or cola colored urine, facial or body edema, hypertension and oliguria
acute nephritic syndrome
what is the most common cause of gross hematuria
bacterial urinary tract infection
urethral bleeding in the absence of urine associated with dysuria and blood spots on underwear after voiding which occurs in prepubertal boys
Urethrorrhagia
most common chronic glomerular disease
IgA nephropathy (Berger disease)
*IgA deposits in mesangium often accompanied by C3 complement
diagnosis of IgA nephropathy requires
renal biopsy
*mesangial proliferation that may be associated with epithelial cell crescent formation and sclerosis
what are the clinical manifestations of IgA nephropathy
gross hematuria often occurs 1-2 days of onset of an URTI or GI infection
C3 level in IgA nephropathy is
normal
primary treatment of IgA nephropathy
appropriate BP control
*other treatment: ACE inhibitors and ARB effective in reducing proteinemia and retarding rate of disease progression
Alport syndrome is caused by mutations in
genes coding for Type IV collagen
electron miscroscopy findings in Alport syndrome
diffuse thickening, thinning, splitting and layering of the glomerular and tubular basement membranes
what are the clinical manifestations of Alport Syndrome
single or recurrent gross hematuria after URTI
progressive proteinuria exceeding 1g/24hr
bilateral sensorineural hearing loss
ocular abnormalities including anterior lenticonus, macular flecks and corneal erosions
pathognomonic of Alport syndrome
anterior lenticonus
sudden onset of gross hematuria, edema, hypertension and renal insufficiency
Acute Poststreptococcal Glomerulonephritis
immunofluorescence microscopic findings in patients with PSGN
“lumpy bumpy” deposits of immunoglobulin and complement on the GBM and mesangium
C3 levels in PSGN
low
nephritogenic strain in PSGN
Group A streptococcus which posses M protein
patient develop acute nephritic syndrome after ___ weeks after streptococcal pharyngitis and ___ weeks after streptococcal pyoderma
1-2 weeks after pharyngitis
3-6 weeks after pyoderma
acute phase of PSGN resolves within
6-8 weeks
commonly elevated after streptococcal pharyngitis
ASO
best single antibody titer to document cutaneous streptococcal infection
anti-DNAse B level
treatment for PSGN
10 day course of Penicillin recommended to limit spread of nephritogenic organisms, antibiotic therapy does not affect the natural history of GN
most common cause of membranous glomerulopathy worldwide
Malaria
- diffuse thickening of the GBM without significant cell proliferative changes
- in situ immune complex formation
treatment for Membranous Glomerulopathy
Immunosuppressive therapy
also known as mesangiocapillary glomerulonephritis
Membranoproliferative GN
- most common in 2nd decade of life
- C3 levels remains persistently low
most common type of MPGN
Type I
- glomeruli have accentuated lobular pattern from diffuse mesangial expansion
- crescents if present signify poor prognosis
indications for renal biopsy
nephrotic syndrome in an older child
significant proteinuria with microscopic hematuria
hypocomplementemia lasting >/=2 months in a child with acute nephritis
most important cause of morbidity and mortality in SLE
Glomerulonephritis
minimal mesangial lupus nephritis
no histologic abnormalities on light microscopy but mesangial immune deposits are present on IF or EM
WHO Class I nephritis
mesangial proliferative nephritis
WHO Class II nephritis
proliferative nephritis; <50% glomeruli involvement
WHO Class III nephritis
proliferative nephritis; >50% glomeruli involvement
WHO Class IV nephritis
membranous lupus nephritis
WHO Class V nephritis
therapy given in Lupus nephritis
Prednisone
may be given in WHO Class I or II Lupus nephritis
Azathioprine
most common small vessel vasculitis
HSP
clinical manifestations of HSP
purpuric rash
arthritis
abdominal pain
when should urinalysis be requested in patients with HSP?
weekly in patients with HSP during period of active clinical disease and once a month for up to 6 months thereafter
when should treatment be given to patients with HSP nephritis?
severe HSP nephritis
>50% crescents on biopsy
hallmark of Rapidly progressive GN
crescents in glomeruli
characterized by pulmonary hemorrhage and glumerulonephritis
Goodpasture Disease
treatment for Goodpasture disease
high dose IV methylpred, cyclophosphamide and plasmapharesis
triad of HUS
renal insufficiency
thrombocytopenia
microangiopathic hemolytic anemia
most common cause of HUS
toxin-producing E. coli that cause prodromal acute enteritis
what are the early glomerular changes in HUS
thickening of capillary walls caused by swelling of endothelial cells and accumulation of fibrillary material between endothelial cells and underlying basement membrane causing narrowing of capillary lumen
characteristic of all forms of HUS
microvascular injury
endothelial cell damage
prognosis in HUS
those with HUS not associated with diarrhea is more severe
common causes of renal vein thrombosis in infants and newborn
asphyxia dehydration shock sepsis congenital hypercoaguable state maternal diabetes
common causes of renal vein thrombosis in older children
nephrotic syndrome cyanotic heart disease inherited hypercoaguable state sepsis following kidney transplantation
sudden onset of gross hematuria and unilateral or bilateral flank mass
Renal vein thrombosis
primary treatment for renal vein thrombosis
supportive care
correction of fluid and electrolytes
treatment of renal insufficiency
treatment for patients with thrombosis of inferior vena cava
can require surgical thrombectomy